Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kevin Judice

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
Semi-synthetic glycopeptide antibacterialsJ Kevin Judice, John L Pace
Current Opinion in Investigational Drugs (London, England : 2000)|March 9, 2005
Telavancin (Theravance)John L Pace, J Kevin Judice
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Vancomycin disulfide derivatives as antibacterial agentsYongQi Mu, Matthew Nodwell, John L Pace, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
In vitro activity of TD-6424 against Staphylococcus aureusJohn L Pace, Kevin Krause, Deborah Johnston, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteriaSharath S Hegde, Noe Reyes, Tania Wiens, et al.
The Journal of Antibiotics|January 27, 2009
A multivalent approach to drug discovery for novel antibioticsDaniel D Long, James B Aggen, Burton G Christensen, et al.
Journal of the American Chemical Society|June 6, 2003
Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimersJohn H Griffin, Martin S Linsell, Matthew B Nodwell, et al.
The Journal of Antibiotics|January 27, 2009
Exploring the positional attachment of glycopeptide/beta-lactam heterodimersDaniel D Long, James B Aggen, Jason Chinn, et al.
The Journal of Antibiotics|August 12, 2004
Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424)Michael R Leadbetter, Stacy M Adams, Bettina Bazzini, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
Semi-synthetic glycopeptide antibacterialsJ Kevin Judice, John L Pace
Current Opinion in Investigational Drugs (London, England : 2000)|March 9, 2005
Telavancin (Theravance)John L Pace, J Kevin Judice
Bioorganic & Medicinal Chemistry Letters|January 27, 2004
Vancomycin disulfide derivatives as antibacterial agentsYongQi Mu, Matthew Nodwell, John L Pace, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
In vitro activity of TD-6424 against Staphylococcus aureusJohn L Pace, Kevin Krause, Deborah Johnston, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteriaSharath S Hegde, Noe Reyes, Tania Wiens, et al.
The Journal of Antibiotics|January 27, 2009
A multivalent approach to drug discovery for novel antibioticsDaniel D Long, James B Aggen, Burton G Christensen, et al.
Journal of the American Chemical Society|June 6, 2003
Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimersJohn H Griffin, Martin S Linsell, Matthew B Nodwell, et al.
The Journal of Antibiotics|January 27, 2009
Exploring the positional attachment of glycopeptide/beta-lactam heterodimersDaniel D Long, James B Aggen, Jason Chinn, et al.
The Journal of Antibiotics|August 12, 2004
Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424)Michael R Leadbetter, Stacy M Adams, Bettina Bazzini, et al.
Pageof 1